AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$STIM

Neuronetics, Inc.

Price · $STIMvia TradingView
AI sentiment · 7d1 articles
MAY 22net (bullish − bearish)MAY 28
Bullish
1
Neutral
0
Bearish
0
Insider · 30dFeed →

No SEC Form 4 filings for $STIM in the last 30 days.

Top stories · $STIMMore →
MAY 27·manilatimes.netLow

PRISM MarketView Spotlights Seven Public Companies Advancing Mental Health Innovation During National Mental Health Awareness Month

PRISM MarketView highlighted seven public companies developing mental health therapies, devices, and digital platforms during National Mental Health Awareness Month. Featured firms include Helus Pharma (HELP), GH Research (GHRS), AtaiBeckley (ATAI), Definium Therapeutics (DFTX), BrainsWay (BWAY), Neuronetics (STIM), and Talkspace (TALK), spanning psychedelic-derived treatments, TMS, and virtual care.

APR 30·Stock Titan

STIM SEC Filings - Neuronetics 10-K, 10-Q, 8-K Forms

This page on Stock Titan offers a comprehensive resource for Neuronetics (STIM) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms. It highlights how Neuronetics, a medical technology company focusing on NeuroStar Advanced Therapy and Greenbrook TMS treatment centers, reports its financial performance, capital structure, and risks. The article also provides summaries of recent filings, including insider transactions, leadership changes, and financial results.

APR 29·The Manila Times

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics, Inc. announced inducement awards granted to six new non-executive employees under Nasdaq Listing Rule 5635(c)(4). These awards, primarily Restricted Stock Units (RSUs), were approved by the Compensation Committee as a material inducement for their employment. The vesting of these awards is contingent upon the employees' continued service with the company through the specified vesting dates.

News on $STIM